Quantcast

Industry news that matters to you.  Learn more

Meso Scale Discovery Launches V-PLEXTM Multiplex Biomarker Immunoassays

Meso Scale Discovery, a division of Meso Scale Diagnostics, LLC. (MSDĀ®), recently announced the global launch of its V-PLEX biomarker tests, a new line of fully validated immunoassays for clinical research.

Immunogenicity Testing Proves Invaluable

Immunogenicity is a measure of the immune response to a biotherapeutic drug. It is a very relevant issue affecting not only the use of therapeutic protein drugs such as mAbs but also peptides, enzymes, cytokines, growth factors, recombinant proteins, and other biological products.